India's Pharmaceutical Market Sees 10.3% Growth in April Driven by Chronic Disease Demand
India's pharma market grows 10.3% in April on strong chronic performance
Business Standard
Image: Business Standard
India's pharmaceutical market (IPM) experienced a 10.3% growth in April 2023, fueled by increased demand for therapies related to chronic diseases such as diabetes, cardiac issues, and respiratory conditions. This growth reflects a positive trend across nearly all major therapy categories.
- 01India's pharmaceutical market grew by 10.3% in April 2023.
- 02Strong demand for anti-diabetes, cardiac, and respiratory therapies drove this growth.
- 03Most major therapy categories showed positive value growth.
- 04Market research firm Pharmarack reported these findings.
- 05The growth indicates a robust performance in the healthcare sector.
Advertisement
In-Article Ad
In April 2023, India's pharmaceutical market (IPM) recorded a significant growth of 10.3%, according to market research firm Pharmarack. This increase was primarily driven by heightened demand for therapies targeting chronic conditions, including anti-diabetes, cardiac, and respiratory treatments. Nearly all major therapy categories contributed positively to this growth, showcasing a strong performance in the healthcare sector. The ongoing focus on chronic disease management is likely to continue influencing the market dynamics as healthcare needs evolve in the country.
Advertisement
In-Article Ad
The growth in the pharmaceutical market suggests increased availability and access to essential medications for chronic disease management, potentially improving health outcomes for patients.
Advertisement
In-Article Ad
Reader Poll
Do you believe the growth in the pharmaceutical market will lead to better healthcare access for chronic disease patients?
Connecting to poll...
More about Pharmarack
Read the original article
Visit the source for the complete story.